Completed NA INTERVENTIONAL 2-arm NCT01837121

a Trial of Using SMS Reminder Among Diabetic Retinopathy Patients in Rural China (SMS)

a Randomized Controlled Trail to Determine the Impact of a SMS Reminder Among Diabetic Retinopathy Patients in Rural China

Sponsor: Orbis

Conditions Compliance Diabetic Retinopathy SMS

Interventions the SMS reminder message

Updated 6 times since 2017 Last updated: Jan 7, 2018 Started: Jan 31, 2015 Primary completion: Jun 30, 2017 Completion: Jun 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01837121, this NA trial focuses on Compliance and Diabetic Retinopathy and remains completed. Sponsored by Orbis, it has been updated 6 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2018 — Jun 2018 [monthly]

Completed NA

Status: Active Not Recruiting → Completed

▶ Show 1 earlier version

Jan 2017 — Jan 2018 [monthly]

Active Not Recruiting NA

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Orbis
Sun Yat-sen University
The World Diabetes Foundation

Data source: Sun Yat-sen University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China